NCT/Study#
NCT04370704 /
INCAGN2385-201
A Phase 1-2 Study Of Combination Therapy With INCMGA00012 (Anti PD-1), INCAGN02385 (Anti LAG-3), And INCAGN02390 (Anti TIM-3) In Participants With Select Advanced Malignancies
DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I/II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
